A shareholder class action lawsuit has been filed against Pomdoctor Ltd., alleging the company was involved in a fraudulent stock promotion scheme that included misinformation on social media and the use of offshore accounts to coordinate share dumping during a price inflation campaign. The lawsuit claims Pomdoctor failed to disclose these activities in its public statements and risk disclosures. Investors who purchased shares between October 9, 2025, and December 11, 2025, may be eligible to seek lead plaintiff status, with an application deadline of April 6, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602170806PRIMZONEFULLFEED9655374) on February 17, 2026, and is solely responsible for the information contained therein.
Comments